Evidence map›Paper›PMID 35169816›Full record

ArticlemedRxiv : the preprint server for health sciences2022

Interactions among 17 respiratory pathogens: a cross-sectional study using clinical and community surveillance data.

Roy Burstein, Benjamin M Althouse, Amanda Adler, Adam Akullian, Elizabeth Brandstetter, Shari Cho, Anne Emanuels, Kairsten Fay, Luis Gamboa, Peter Han and 25 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Roy BursteinInstitute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA.
Benjamin M AlthouseInstitute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA.
Amanda AdlerSeattle Children's Research Institute, Seattle WA USA.
Adam AkullianInstitute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA.
Elizabeth BrandstetterDepartment of Medicine, University of Washington, Seattle WA USA.
Shari ChoBrotman Baty Institute for Precision Medicine, Seattle WA USA.
Anne EmanuelsDepartment of Medicine, University of Washington, Seattle WA USA.
Kairsten FayVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA.
Luis GamboaBrotman Baty Institute for Precision Medicine, Seattle WA USA.
Peter HanBrotman Baty Institute for Precision Medicine, Seattle WA USA.
Kristen HudenDepartment of Medicine, University of Washington, Seattle WA USA.
Misja IlcisinVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA.
Mandy IzzoInstitute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA.
Michael L JacksonKaiser Permanente Washington Health Research Institute, Seattle WA USA.
Ashley E KimDepartment of Medicine, University of Washington, Seattle WA USA.
Louise KimballVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA.
Kirsten LacombeSeattle Children's Research Institute, Seattle WA USA.
Jover LeeVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA.
Jennifer K LogueDepartment of Medicine, University of Washington, Seattle WA USA.
Julia RogersDepartment of Medicine, University of Washington, Seattle WA USA.
Erin ChungDepartment of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle.
Thomas R SibleyVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA.
Katrina Van RaayBrotman Baty Institute for Precision Medicine, Seattle WA USA.
Edward WengerInstitute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA.
Caitlin R WolfDepartment of Medicine, University of Washington, Seattle WA USA.
Michael BoeckhDepartment of Medicine, University of Washington, Seattle WA USA.
Helen ChuDepartment of Medicine, University of Washington, Seattle WA USA.
Jeff DuchinDepartment of Medicine, University of Washington, Seattle WA USA.
Mark RiederBrotman Baty Institute for Precision Medicine, Seattle WA USA.
Jay ShendureBrotman Baty Institute for Precision Medicine, Seattle WA USA.
Lea M StaritaBrotman Baty Institute for Precision Medicine, Seattle WA USA.
Cecile ViboudDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.
Trevor BedfordBrotman Baty Institute for Precision Medicine, Seattle WA USA.
Janet A EnglundSeattle Children's Research Institute, Seattle WA USA.
Michael FamulareInstitute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle WA USA.

Funding

Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigationR35GM119774 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2016 to 2025
$4.1M
NIGMS NIH HHS R35 GM119774
6 · The paper itself

Abstract

Background: Co-circulating respiratory pathogens can interfere with or promote each other, leading to important effects on disease epidemiology. Estimating the magnitude of pathogen-pathogen interactions from clinical specimens is challenging because sampling from symptomatic individuals can create biased estimates. Methods: We conducted an observational, cross-sectional study using samples collected by the Seattle Flu Study between 11 November 2018 and 20 August 2021. Samples that tested positive via RT-qPCR for at least one of 17 potential respiratory pathogens were included in this study. Semi-quantitative cycle threshold (Ct) values were used to measure pathogen load. Differences in pathogen load between monoinfected and coinfected samples were assessed using linear regression adjusting for age, season, and recruitment channel. Results: 21,686 samples were positive for at least one potential pathogen. Most prevalent were rhinovirus (33·5%), Conclusions: Viral load data can be used to overcome sampling bias in studies of pathogen-pathogen interactions. When applied to respiratory pathogens, we found evidence of viral-

Identifiers

PMID35169816
PMCPMC8845514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.